Impact of Omega-3 Fatty Acids on Lactate

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Pre- and intra-operative nutritional support in patient undergoing major surgery results in decreased morbidity and mortality. Studies investigating the role of omega-3 fatty acids in these patients are increasing. Some are focused on perfusion at the cellular level. This study was undertaken to address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05759689` - Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery	N/A
	Completed	`NCT00417651` - Testing for Bacterial Contamination During Gastric Surgeries	Phase 1

NCT number	NCT00929461
Study type	Interventional
Source	Ege University
Contact
Status	Completed
Phase	N/A

Impact of Omega-3 Fatty Acids on Lactate

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms